Experienced Materials/Medical Device Executive Doug Nutter to Oversee Manufacturing, Quality and Engineering for the World’s Only Approved Total Artificial Heart
SynCardia Systems, Inc. has named Douglas Nutter its new Chief Operating Officer. Mr. Nutter will oversee manufacturing, quality and engineering for the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.
“Doug has an extensive background in materials similar to those used in the SynCardia temporary Total Artificial Heart,” said Michael Garippa, SynCardia CEO/president/chairman. “In addition, his expertise in organizational development and excellence, along with his proven track record of creating profitable product-market strategies for growth, will be an incredible asset to our company.”
Mr. Nutter received an S.B. in Physics from MIT and began his career as a materials physicist for Hercules. He joined GE’s plastic business in 1977 where he worked for 20 years. As President of Exatec, LLC, he led the formation, negotiation and start-up of a joint venture between GE and Bayer for lightweight, life-saving polycarbonate automotive windows. After 25 years in the materials industry, Mr. Nutter spent 10 years in optics-based medical devices as Vice President of Business Development at Optical Research Associates, and General Manager of Electro-Optics at Zygo Corporation…
read more at SynCardia.com.